|
![]() |
|||
|
||||
OverviewWritten by experts in the dermatology field, the new Third Edition of Moderate-to-Severe Psoriasis discusses the current use of biologics and new pharmacologic and phototherapy treatments for moderate-to-severe psoriasis. With 80 high quality color figures and full color throughout, this stand-alone text emphasizes safe and effective treatments for the psoriasis patient that are perfect for the dermatologist in daily practice. New to the Third Edition: the addition of chapters on the use of infliximab, efalizumab, and Humera, as well as the latest status of clinical trials the most up-to-date phototherapy and laser treatment modalities stronger coverage of psoriatic arthritis Full Product DetailsAuthor: John Y. M. Koo (University of California at San Francisco, USA) , Chai Sue Lee , Mark G. Lebwohl (Mount Sinai School of Medicine, New York, New York, USA) , Ethan C. Levin (University of California at San Francisco, USA)Publisher: Taylor & Francis Inc Imprint: Informa Healthcare Edition: 3rd New edition Dimensions: Width: 15.20cm , Height: 2.00cm , Length: 22.90cm Weight: 0.794kg ISBN: 9781420088670ISBN 10: 142008867 Pages: 414 Publication Date: 22 December 2008 Audience: Professional and scholarly , Professional & Vocational , Professional & Vocational Replaced By: 9781482215168 Format: Hardback Publisher's Status: Out of Print Availability: Awaiting stock ![]() Table of Contents1. An Overview of Psoriasis. 2. Evaluating Psoriasis in Patients. 3. Topical Agents in the Treatment of Moderate-to-Severe Psoriasis. 4. The Art and Practice of UVB Phototherapy and Laser for the Treatment of Moderate-to-Severe Psoriasis. 5. Systemic and Topical PUVA Therapy. 6. Therapy of Moderate-to-Severe Psoriasis with Methotrexate. 7. Systemic Retinoids. 8. Cyclosporine in the Treatment of Severe Psoriasis. 9. Combination, Rotational, and Sequential Therapy. 10. Pediatric Psoriasis. 11. Psoriatic Arthritis. 12. Etanercept for Treatment of Psoriasis and Psoriatic Arthritis. 13. Adalimumab in the Treatment of Psoriasis. 14. Infliximab in the Treatment of Psoriasis. 15. Efalizumab in the Treatment of Psoriasis. 16. Alefacept for Treatment of Psoriasis. 17. Ustekinumab and ABT-874. 18. The Immunomodulatory/Immunosuppressive Classification System. 19. Current and Potential Applications of Pharmacogenetics and Pharmacogenomics in the Treatment of Psoriasis.ReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |